CTLA-4 blockade in mesothelioma: ineffective or reason for optimism?

Lancet Oncol. 2017 Sep;18(9):1150-1151. doi: 10.1016/S1470-2045(17)30511-9. Epub 2017 Jul 17.

Authors

Anish Thomas¹, Raffit Hassan²

Affiliations

¹ Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
² Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: [email protected].

PMID: 28729153
DOI: 10.1016/S1470-2045(17)30511-9

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal
CTLA-4 Antigen*
Humans
Lung Neoplasms
Mesothelioma*

Substances

Antibodies, Monoclonal
CTLA-4 Antigen